Intesa Sanpaolo S.p.A.

Position in ABCL — AbCellera Biologics Inc.

CIK 1374384 TURIN, L6

Position in ABCL

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$157,000

-$416,654 QoQ

Shares Held

20,000

-87.8% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#97

of 150 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Intesa Sanpaolo S.p.A. holds $1,347,981 across 4 Biotechnology names. ABCL ranks #4 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	7,701	$602,757
2	REGN	Regeneron Pharmaceuticals, Inc.	670	$417,771
3	MRNA	Moderna, Inc.	2,434	$170,453
4	ABCL	AbCellera Biologics Inc. This page	20,000	$157,000

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$157,000	20,000	-87.8%	Shares	Defined	2026-07-31
2026-03-31	$573,654	164,371	-9.9%	Shares	Defined	2026-05-15
2025-12-31	$624,050	182,471	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.